Supportive Analgesic Effect of Auricular Acupressure (AA) After Cesarean Section (CS)
AA-CS
Evaluation of the Supportive Analgesic Effect of Auricular Acupressure After Cesarean Section: A Randomized Clinical Controlled Trial
1 other identifier
interventional
70
1 country
1
Brief Summary
Introduction: Severe acute pain after cesarean section is an independent risk factor for the development of chronic pain and increases the risk of postpartum depression threefold. Pain also reduces the mother's ability to breastfeed and care for her child. This study aimed to evaluate the supportive effectiveness of auricular acupressure in reducing incision pain and uterine contraction pain in women undergoing cesarean section, compared with sham auricular acupressure. Methods: A randomized, controlled, single-blind clinical trial was conducted in seventy women undergoing cesarean section, randomly allocated (1:1) to an auricular acupressure or sham group. The study group received vaccaria seeds, and the sham group received non-vaccaria patches on both ears. Both groups were treated at the Shenmen, Lung, Internal Genitalia, Pelvis, Subcortex, and Sympathetic points. Pain was assessed using the Visual Analog Scale (VAS), and diclofenac consumption was recorded over the first 48 hours postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedJanuary 7, 2026
October 1, 2025
9 months
December 14, 2025
December 29, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section.
Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (zero) represents no pain and the right-most point (10) represents extreme pain. The higher the score, the more severe the pain.
12, 24, 48 hours postoperative
VAS scores for pain intensity at rest, pain intensity on movement, and uterine contraction pain
Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (0) represents 'no pain,' while the right-most point (10) represents 'extreme pain.' The higher the score, the more severe the pain.
From enrollment to the end of treatment at 48 hours
Study Arms (2)
Auricular Acupressure Group
EXPERIMENTALParticipants received auricular acupressure using Vaccaria seeds applied to Shenmen \[Antitragus-4 (TF4)\], Lung \[Concha-14 (CO14)\], Internal Genitalia \[Triangular fossa-2 (TF2)\], Pelvis \[Triangular fossa-5 (TF5)\], Subcortex \[Antitragus-4 (AT4)\], and Sympathetic \[Antihelix-6 (AH6)\].
Sham Auricular Acupressure Group
SHAM COMPARATORParticipants received identical adhesive patches without seeds applied to the same auricular points.
Interventions
In the Auricular Acupressure group, participants received auricular acupressure using vaccaria seeds applied to the following points on both ears: Ear Shenmen (TF4), Lung (CO14), Internal Genitalia (TF2), Pelvis (TF5), Subcortex (AT4), and Sympathetic (AH6), in addition to standard postoperative care. Each participant received a single treatment session within 5 hours after cesarean section, once transferred to the Obstetrics Department. Seeds were retained for 2 days. All acupuncture procedures were performed by licensed traditional medicine physicians who had been trained and standardized before the study.
In the Sham Auricular Acupressure Group, participants received adhesive patches without seeds, identical in size and appearance to the Auricular Acupressure Group patches, applied to the same auricular points. Both groups received standard postoperative care.
Eligibility Criteria
You may qualify if:
- years of age
- Gestational age ≥ 37 weeks
- Alert and cooperative with the treating physicians
- Able to understand and use the Visual Analog Scale (VAS)
- Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification System I-II
- Anesthesia: spinal anesthesia;
- Pfannenstiel suprapubic transverse incision
- Infant 5-minute Appearance, Pulse, Grimace, Activity, Respiration score (Apgar score) \> 7
- Cesarean operative time ≤ 60 minutes
- Singleton pregnancy
- Voluntary agreement to participate.
You may not qualify if:
- Contraindication to diclofenac
- Surgical complications, including hysterectomy and postpartum hemorrhage (\> 1000 ml)
- History of acupuncture syncope
- Preoperative chronic pain and/or regular preoperative use of analgesics
- Addiction to or dependence on opioids or alcohol
- Diabetes mellitus or HIV infection
- Prior Auricular acupressure
- Skin lesions of the auricle
- Surgical wound infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Le Van Thinh Hospital
Ho Chi Minh City, Binh Trung Ward, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ly, PhD
University of Medicine and Pharmacy at Ho Chi Minh City
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 14, 2025
First Posted
January 7, 2026
Study Start
October 14, 2024
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
January 7, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 3 years after the publication of results
- Access Criteria
- Data will be made available to qualified researchers for the purpose of valid scientific research. To gain access, investigators must submit a formal research proposal and a statistically sound analysis plan to the Principal Investigator. All requests will be reviewed by the study's investigators and the Institutional Ethics Committee. Upon approval, requestors will be required to sign a Data Use Agreement (DUA) to ensure participant confidentiality. The shared data will be de-identified and may include the study protocol and statistical analysis plan.
The type of data set or supporting information being shared. Options include: study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code.